This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Maigaard, S Articles by Madsen, P O Search for Related Content PubMed PubMed Citation Articles by Maigaard, S Articles by Madsen, P O

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 411-416

Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.

S Maigaard, N Frimodt-Möller, P G Welling and P O Madsen

ABSTRACT

The pharmacokinetics of cinoxacin, a new antibacterial compound related to nalidixic acid and oxolinic acid, were investigated in 22 patients with varying degrees of renal impairment. After oral administration of cinoxacin at 500 mg every 12 h for 7 days to all patients, the drug was found to be well tolerated. The urine concentrations of cinoxacin in all patients far exceeded the minimal inhibitory concentrations for susceptible organisms commonly found in urinary tract infections. The serum half-life of cinoxacin in patients with normal renal function was approximately 2.7 h but increased to approximately 8.5 h in patients with creatinine clearance less than 30 ml/min. No undue drug accumulation was demonstrated in any patient group during the treatment. Highly significant correlations were found between the elimination rate constant and creatinine clearance and also between the elimination half-life and serum creatinine. The bioavailability of cinoxacin was independent of renal function.

---

Antimicrob Agents Chemother. 1979 September; 16(3): 411-416